Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Malaria Journal
Published in: Malaria Journal 1/2020

01-12-2020 | Malaria | Review

The potential of anti-malarial compounds derived from African medicinal plants: a review of pharmacological evaluations from 2013 to 2019

Authors: Boris D. Bekono, Fidele Ntie-Kang, Pascal Amoa Onguéné, Lydia L. Lifongo, Wolfgang Sippl, Karin Fester, Luc C. O. Owono

Published in: Malaria Journal | Issue 1/2020

Login to get access

Abstract

Background

African Traditional Medicine (ATM) is used for the healthcare of about 80% of the rural populations of the continent of Africa. The practices of ATM make use of plant-products, which are known to contain plant-based secondary metabolites or natural products (NPs), likely to play key roles in drug discovery, particularly as lead compounds. For various reasons, including resistance of strains of Plasmodium to known anti-malarial drugs, local African populations often resort to plant-based treatments and/or a combination of this and standard anti-malarial regimens. Emphasis has been laid in this review to present the anti-malarial virtue of the most recently published phytochemicals or natural products, which have been tested by in vitro and in vivo assays.

Methods

The data was based on the current version of the African Compound Libraries, which are constantly being updated based on inputs from journal articles and student theses (M.Sc/Ph.D) from African University libraries. Emphasis was laid on data published after 2012. In order to carry out the original data collection, currently being included in the African Compounds Database, individual journal websites were queried using the country names in Africa as search terms. Over 40,000 articles “hits” were originally retrieved, then reduced to about 9000 articles. The retained articles/theses was further queried with the search terms “malaria”, “malarial”, “plasmodium”, “plasmodial” and a combination of them, resulting in over 500 articles. Those including compounds with anti-malarial activities for which the measured activities fell within the established cut off values numbered 55, which were all cited in the review as relevant references.

Results and discussion

Pure compounds derived from African medicinal plants with demonstrated anti-malarial/antiplasmodial properties with activities ranging from “very active” to “weakly active” have been discussed. The majority of the 187 natural products were terpenoids (30%), followed by flavonoids (22%), alkaloids (19%) and quinones (15%), with each of the other compound classes being less than 5% of the entire compound collection. It was also observed that most of the plant species from which the compounds were identified were of the families Rubiaceae, Meliaceae and Asphodelaceae. The review is intended to continue laying the groundwork for an African-based anti-malarial drug discovery project.
Appendix
Available only for authorised users
Literature
1.
2.
Mosnier E, Roux E, Cropet C, Lazrek Y, Moriceau O, Gaillet M, et al. Prevalence of Plasmodium spp. in the Amazonian border context (French Guiana-Brazil): associated factors and spatial distribution. Am J Trop Med Hyg. 2019;102:130–41.PubMedCentralCrossRef
3.
Haeseleer C, Martiny D, Van Laethem Y, Cantinieaux B, Martin C. Reactivation of Plasmodium infection during a treatment with infliximab: a case report. Int J Infect Dis. 2019;91:101–3.PubMedCrossRef
4.
Musyoka KB, Kiiru JN, Aluvaala E, Omondi P, Chege WK, Judah T, et al. Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya. Infect Genet Evol. 2019;78:104121.PubMedCrossRef
5.
Sumarnrote A, Overgaard HJ, Marasri N, Fustec B, Thanispong K, Chareonviriyaphap T, et al. Status of insecticide resistance in Anopheles mosquitoes in Ubon Ratchathani province, Northeastern Thailand. Malar J. 2017;16:299.PubMedPubMedCentralCrossRef
6.
Chaumeau V, Cerqueira D, Zadrozny J, Kittiphanakun P, Andolina C, Chareonviriyaphap T, et al. Insecticide resistance in malaria vectors along the Thailand–Myanmar border. Parasit Vectors. 2017;10:165.PubMedPubMedCentralCrossRef
7.
Rakotoson JD, Fornadel CM, Belemvire A, Norris LC, George K, Caranci A, et al. Insecticide resistance status of three malaria vectors, Anopheles gambiae (s.l.), An. funestus and An. mascarensis, from the south, central and east coasts of Madagascar. Parasit Vectors. 2017;10:396.PubMedPubMedCentralCrossRef
8.
Hanscheid T, Schlagenhauf P, Grobusch MP. Atovaquone/proguanil for malaria chemoprophylaxis—could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure? Travel Med Infect Dis. 2019;20:101527.
9.
Schlagenhauf P, Grobusch MP, Leder K, Toovey S, Patel D. Complex choices: which malaria chemoprophylaxis can be recommended for the pregnant traveller? Travel Med Infect Dis. 2019;20:101525.CrossRef
10.
Haston JC, Hwang J, Tan KR. Guidance for using tafenoquine for prevention and antirelapse therapy for malaria—United States, 2019. MMWR. 2019;68:1062–8.PubMed
11.
Hassett MR, Riegel BE, Callaghan PS, Roepe PD. Analysis of Plasmodium vivax chloroquine resistance transporter mutant isoforms. Biochemistry. 2017;56:5615–22.PubMedCrossRef
12.
Zhang M, Wang C, Otto TD, Oberstaller J, Liao X, Adapa SR, et al. Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis. Science. 2018;360:eaap7847.PubMedPubMedCentralCrossRef
13.
Parobek CM, Parr JB, Brazeau NF, Lon C, Chaorattanakawee S, Gosi P, et al. Partner-drug resistance and population substructuring of artemisinin-resistant Plasmodium falciparum in Cambodia. Genome Biol Evol. 2017;9:1673–86.PubMedPubMedCentralCrossRef
14.
Pinheiro LCS, Feitosa LM, Gandi MO, Silveira FF, Boechat N. The development of novel compounds against malaria: quinolines, triazolpyridines, pyrazolopyridines and pyrazolopyrimidines. Molecules. 2019;24:E4095.CrossRef
15.
Okello D, Kang Y. Exploring antimalarial herbal plants across communities in Uganda based on electronic data. Evid Based Complement Altern Med. 2019;2019:3057180.CrossRef
16.
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2013;4:177.
17.
Bodeker C, Bodeker G, Ong CK, Grundy CK, Burford G, Shein K. WHO global atlas of traditional, complementary and alternative medicine. Geneva: World Health Organization; 2005.
18.
Alebie G, Urga B, Worku A. Systematic review on traditional medicinal plants used for the treatment of malaria in Ethiopia: trends and perspectives. Malar J. 2017;16:307.PubMedPubMedCentralCrossRef
19.
Esmaeili S, Ghiaee A, Naghibi F, Mosaddegh M. Antiplasmodial activity and cytotoxicity of plants used in traditional medicine of Iran for the treatment of fever. Iran J Pharm Res. 2015;14:103–7.PubMedPubMedCentral
20.
Mukungu N, Abuga K, Okalebo F, Ingwela R, Mwangi J. Medicinal plants used for management of malaria among the Luhya community of Kakamega East sub-County, Kenya. J Ethnopharmacol. 2016;194:98–107.PubMedPubMedCentralCrossRef
21.
Appiah KS, Oppong CP, Mardani HK, Omari RA, Kpabitey S, Amoatey CA, et al. Medicinal plants used in the Ejisu-Juaben Municipality, Southern Ghana: an ethnobotanical study. Medicines (Basel). 2019;6:1.
22.
Salehi B, Zakaria ZA, Gyawali R, Ibrahim SA, Rajkovic J, Shinwari ZK, et al. Piper species: a comprehensive review on their phytochemistry, biological activities and applications. Molecules. 2019;24:1364.PubMedCentralCrossRef
23.
24.
Youmsi RDF, Fokou PVT, Menkem EZ, Bakarnga-Via I, Keumoe R, Nana V, et al. Ethnobotanical survey of medicinal plants used as insects repellents in six malaria endemic localities of Cameroon. J Ethnobiol Ethnomed. 2017;13:33.PubMedPubMedCentralCrossRef
25.
26.
Tshitenge DT, Ioset KN, Lami JN, Ndelo-di-Phanzu J, Mufusama J-PKS, Bringmann G. Rational quality assessment procedure for less-investigated herbal medicines: case of a Congolese antimalarial drug with an analytical report. Fitoterapia. 2016;110:189–95.PubMedCrossRef
27.
Onguéné PA, Ntie-Kang F, Lifongo LL, Ndom JC, Sippl W, Mbaze LM. The potential of anti-malarial compounds derived from African medicinal plants, part I: a pharmacological evaluation of alkaloids and terpenoids. Malar J. 2013;12:449.CrossRef
28.
Ntie-Kang F, Onguéné PA, Lifongo LL, Ndom JC, Sippl W, Mbaze LM. The potential of anti-malarial compounds derived from African medicinal plants, part II: a pharmacological evaluation of non-alkaloids and non-terpenoids. Malar J. 2014;13:81.PubMedPubMedCentralCrossRef
29.
Mahmoudi N, de Julian-Ortiz JV, Cicerone L, Galvez J, Mazier D, Danism M, et al. Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening. J Antimicrob Chemother. 2006;57:489–97.PubMedCrossRef
30.
Willcox M, Bodeker G, Rasanaivo P. Traditional medicinal plants and malaria. Boca Raton: CRC Press; 2004.
31.
Rasoanaivo P, Oketch-Rabah H. Preclinical considerations on anti-malarial phytomedicines. Part II, Efficacy evaluation. Antananarivo: Institut Malgache de Recherches Appliquées; 1998.
32.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3–26.PubMedCrossRef
33.
Onguéné PA, Ntie-Kang F, Mbah JA, Lifongo LL, Ndom JC, Sippl W, et al. The potential of anti-malarial compounds derived from African medicinal plants, part III: an in silico evaluation of drug metabolism and pharmacokinetics profiling. Org Med Chem Lett. 2014;4:6.PubMedPubMedCentralCrossRef
34.
Ntie-Kang F, Mbah JA, Mbaze LM, Lifongo LL, Scharfe M, Ngo Hanna J, et al. CamMedNP: building the Cameroonian 3D structural natural products database for virtual screening. BMC Complement Altern Med. 2013;13:88.PubMedPubMedCentralCrossRef
35.
Ntie-Kang F, Onguéné PA, Scharfe M, Owono LCO, Megnassan E, Mbaze LM, et al. ConMedNP: a natural product library from Central African medicinal plants for drug discovery. RSC Adv. 2014;4:409–19.CrossRef
36.
Ntie-Kang F, Zofou D, Babiaka SB, Meudom R, Scharfe M, Lifongo LL, et al. AfroDb: a select highly potent and diverse natural product library from African medicinal plants. PLoS ONE. 2013;8:e78085.PubMedPubMedCentralCrossRef
37.
Ntie-Kang F, Telukunta KK, Döring K, Simoben CV, Moumbock AFA, Malange YI, et al. NANPDB: a resource for natural products from Northern African sources. J Nat Prod. 2017;80:2067–76.PubMedCrossRef
38.
Organization for Economic Growth and Development (OECD). OECD guidelines for the testing of chemicals: acute oral toxicity up and down-procedure (UDP). 2008; 1–27.
39.
Dikasso D, Makonnen E, Debella A, Abebe D, Urga K, Makonnen W, et al. In vivo antimalarial activity of hydroalcoholic extracts from Asparagus africanus Lam. in mice infected with Plasmodium berghei. Ethiop J Health Dev. 2006;280:112–8.
40.
Akuodor GC, Idris-Usman M, Anyalewechi N, Eucheria O, Ugwu CT, Akpan JL, et al. In vivo antimalarial activity of ethanolic leaf extract of Verbena hastata against Plasmodium berghei in mice. J Herb Med Toxicol. 2010;4:17–23.
41.
Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979;16:710–8.PubMedPubMedCentralCrossRef
42.
43.
Duffy S, Avery VM. Development and optimization of a novel 384-well antimalarial imaging assay validated for high-throughput screening. Am J Trop Med Hyg. 2012;86:84–92.PubMedPubMedCentralCrossRef
44.
Novac O, Guenier AS, Pelletier J. Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. Nucleic Acids Res. 2004;32:902–5.PubMedPubMedCentralCrossRef
45.
Kigondu EV, Rukunga GM, Keriko JM, Tonui WK, Gathirwa JW, Kirira PG, et al. Antiparasitic activity and cytotoxicity of selected medicinal plants from Kenya. J Ethnopharmacol. 2009;123:504–9.PubMedCrossRef
46.
Gathirwa JW, Rukunga GM, Njagi ENM, Omar SA, Mwitari PG, Guantai AN, et al. The in vitro antiplasmodial and in vivo antimalarial efficacy of combinations of some medicinal plants used traditionally for treatment of malaria by the Meru community in Kenya. J Ethnopharmacol. 2008;115:223–31.PubMedCrossRef
47.
Samoylenko V, Jacob MR, Khan SI, Zhao J, Tekwani BL, Midiwo JO, et al. Antimicrobial, antiparasitic and cytotoxic spermine alkaloids from Albizia schimperiana. Nat Prod Commun. 2009;4:791–6.PubMedPubMedCentral
48.
Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg. 1993;48:739–41.PubMedCrossRef
49.
Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother. 2004;48:1803–6.PubMedPubMedCentralCrossRef
50.
Juma WP, Akala HM, Eyase FL, Muiva LM, Heydenreich M, Okalebo FA, et al. Terpurinflavone: antiplasmodial flavones from the stem of Tephrosia purpurea. Phytochem Lett. 2011;4:176–8.CrossRef
51.
Johnson JA, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC. Assessment and continued validation of the malaria SYBR Green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother. 2007;51:1926–33.PubMedPubMedCentralCrossRef
52.
Makler MT, Hinrichs DJ. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg. 1993;48:205–10.PubMedCrossRef
53.
Matile H, Pink JRL. Chapter 15: Plasmodium falciparum malaria parasite cultures and their use in immunology. In: Lefkovits I, Pernis B, editors. Immunological methods, vol. 4. San Diego: Academic Press; 1990. p. 221–34.CrossRef
54.
Thaithong S, Beale GH, Chutmongkonkul M. Susceptibility of Plasmodium falciparum to five drugs: an in vitro study of isolates mainly from Thailand. Trans R Soc Trop Med Hyg. 1983;77:228–31.PubMedCrossRef
55.
Ahmed SA, Gogal RM, Walsh JE. A new rapid simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods. 1994;170:211–24.PubMedCrossRef
56.
Ponnudurai T, Leeuwenberg AD, Meuwissen JH. Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. Trop Geogr Med. 1981;33:50–4.PubMed
57.
Malik S, Khan S, Das A, Samantaray JC. Plasmodium lactate dehydrogenase assay to detect malarial parasites. Natl Med J India. 2004;17:237–9.PubMed
58.
Malebo HM, Wenzler T, Cal M, Swaleh SM, Omolo MO, Hassanali A, et al. Anti-protozoal activity of aporphine and protoberberine alkaloids from Annickia kummeriae (Engl. & Diels) Setten & Maas (Annonaceae). BMC Complement Altern Med. 2013;13:48.PubMedPubMedCentralCrossRef
59.
Lacroix D, Prado S, Kamoga D, Kasenene J, Bodo B. Absolute configuration of 2′(R)-acetylmontrifoline and 2′(R)-montrifoline, furoquinolines from the fruits of Teclea nobilis. Phytochem Lett. 2012;5:22–5.CrossRef
60.
Rasamison VE, Brodie PJ, Merino EF, Cassera MB, Ratsimbason MA, Rakotonandrasana S, et al. Furoquinoline alkaloids and methoxyflavones from the stem bark of Melicope madagascariensis (Baker) T.G. Hartley. Nat Prod Bioprospect. 2016;6:261–5.PubMedPubMedCentralCrossRef
61.
Tchinda AT, Tamze V, Ngono ARN, Ayimele GA, Cao M, Angenot L, et al. Alkaloids from the stem bark of Strychnos icaja. Phytochem Lett. 2012;5:108–13.CrossRef
62.
Beaufay C, Ledoux A, Jansen O, Bordignon A, Zhao S, Teijaro CN, et al. In vivo antimalarial and antitrypanosomal activity of strychnogucine B, a bisindole alkaloid from Strychnos icaja. Planta Med. 2018;84:881–5.PubMedCrossRef
63.
Frédérich M, De Pauw M-C, Prosperi C, Tits M, Brandt V, Penelle J, et al. Strychnogucines A and B, two new antiplasmodial bisindole alkaloids from Strychnos icaja. J Nat Prod. 2001;64:12–6.PubMedCrossRef
64.
Kouam SF, Ngouonpe AW, Lamshöft M, Talontsi FM, Bauer JO, Strohmann C, et al. Indolosesquiterpene alkaloids from the Cameroonian medicinal plant Polyalthia oliveri (Annonaceae). Phytochemistry. 2014;105:52–9.PubMedCrossRef
65.
Lombe BK, Bruhn T, Feineis D, Mudogo V, Brun R, Bringmann G. Cyclombandakamines A1 and A2, oxygen-bridged naphthylisoquinoline dimers from a Congolese Ancistrocladus liana. Org Lett. 2017;19:1342–5.PubMedCrossRef
66.
Li J, Seupel R, Feineis D, Mudogo V, Kaiser M, Brun R, et al. Dioncophyllines C2, D2, and F and related naphthylisoquinoline alkaloids from the Congolese liana Ancistrocladus ileboensis with potent activities against Plasmodium falciparum and against multiple myeloma and leukemia cell lines. J Nat Prod. 2017;80:443–58.PubMedCrossRef
67.
Tshitenge DT, Bruhn T, Feineis D, Schmidt D, Mudogo V, Kaiser M, et al. Ealamines A-H, a series of naphthylisoquinolines with the rare 7,8′-coupling site, from the Congolese liana Ancistrocladus ealaensis, targeting pancreatic cancer cells. J Nat Prod. 2019;82:3150–64.PubMedCrossRef
68.
Gbedema SY, Bayor MT, Annan K, Wright CW. Clerodane diterpenes from Polyalthia longifolia (Sonn) Thw. var. pendula: Potential antimalarial agents for drug resistant Plasmodium falciparum infection. J Ethnopharmacol. 2015;169:176–82.PubMedCrossRef
69.
Kouam SF, Ngouonpe AW, Bullach A, Lamshöft M, Kuigoua GM, Spiteller M. Monoterpenes with antibacterial activities from a Cameroonian medicinal plant Canthium multiflorum (Rubiaceae). Fitoterapia. 2013;91:199–204.PubMedCrossRef
70.
Betti JL. Medicinal plants sold in Yaoundé markets, Cameroon. Afr Study Monogr. 2002;23:47–64.
71.
Bouquet A, Debray M. Plantes médicinales de la Côte d’Ivoire, vol. 32. Paris: Mémoires Office de la Recherche Scientifique et Technique d’Outre-Mer (O.R.S.T.O.M); 1974. p. 232.
72.
Wafo P, Nyasse B, Fontaine C, Sondengam BL. Aporphine alkaloids from Enantia chlorantha. Fitoterapia. 1999;70:157–60.CrossRef
73.
Lacroix D, Prado S, Kamoga D, Kasenene J, Namukobe J, Krief S, et al. Antiplasmodial and cytotoxic activities of medicinal plants traditionally used in the village of Kiohima, Uganda. J Ethnopharmacol. 2011;133:850–5.PubMedCrossRef
74.
Neuwinger HD. African ethnobotany: poisons and drugs: chemistry, pharmacology, toxicology. Boca Raton: CRC Press; 1996.
75.
Boyom FF, Kemgne EM, Tepongning R, Ngouana V, Mbacham WF, Tsamo E, et al. Antiplasmodial activity of extracts from seven medicinal plants used in malaria treatment in Cameroon. J Ethnopharmacol. 2009;123:483–8.PubMedCrossRef
76.
Kerubo LO, Midiwo JO, Derese S, Langat MK, Akala HM, Waters NC, et al. Antiplasmodial activity of compounds from the surface exudates of Senecio roseiflorus. Nat Prod Commun. 2013;8:175–6.PubMed
77.
Muiva-Mutisya L, Macharia B, Heydenreich M, Koch A, Akala HM, Derese S, et al. 6α-Hydroxy-α-toxicarol and (+)-tephrodin with antiplasmodial activities from Tephrosia species. Phytochem Lett. 2014;10:179–83.CrossRef
78.
Azebaze AGB, Teinkela JEM, Nguemfo EL, Valentin A, Dongmo AB, Vardamides JC. Antiplasmodial activity of some phenolic compounds from Cameroonians Allanblackia. Afr Health Sci. 2015;15:835–40.PubMedPubMedCentralCrossRef
79.
Ngemenya MN, Metuge HM, Mbah JA, Zofou D, Babiaka SB, Titanji VPK. Isolation of natural product hits from Peperomia species with synergistic activity against resistant Plasmodium falciparum strains. Eur J Med Plants. 2015;5:77–87.CrossRef
80.
Irungu BN, Orwa JA, Gruhonjic A, Fitzpatrick PA, Landberg G, Kimani F, et al. Constituents of the roots and leaves of Ekebergia capensis and their potential antiplasmodial and cytotoxic activities. Molecules. 2014;19:14235–46.PubMedPubMedCentralCrossRef
81.
Derese S, Barasa L, Akala HM, Yusuf AO, Kamau E, Heydenreich M, et al. 4′-Prenyloxyderrone from the stem bark of Millettia oblata ssp. teitensis and the antiplasmodial activities of isoflavones from some Millettia species. Phytochem Lett. 2014;31:69–72.CrossRef
82.
Marco M, Deyou T, Gruhonjic A, Holleran JP, Duffy S, Heydenreich M, et al. Pterocarpans and isoflavones from the root bark of Millettia micans and of Millettia dura. Phytochem Lett. 2017;21:216–20.CrossRef
83.
Mbwambo ZH, Moshi MJ, Masimba MJ, Kapingu MC, Nondo RSO. Antimicrobial activity and brine shrimp toxicity of extracts of Terminalia brownii roots and stem. BMC Complement Altern Med. 2007;7:9.PubMedPubMedCentralCrossRef
84.
Machumi F, Midiwo JO, Jacob MR, Khan SI, Tekwani BL, Zhang J, et al. Phytochemical, antimicrobial and antiplasmodial investigations of Terminalia brownii. Nat Prod Commun. 2013;8:761–4.PubMedPubMedCentral
85.
Induli M, Gebru M, Abdissa N, Akala H, Wekesa I, Byamukama R, et al. Antiplasmodial quinones from the rhizomes of Kniphofia foliosa. Nat Prod Commun. 2013;8:1261–4.PubMed
86.
Abdissa N, Induli M, Akala HM, Heydenreich M, Midiwo JO, Ndakala A, et al. Knipholone cyclooxanthrone and an anthraquinone dimer with antiplasmodial activities from the roots of Kniphofia foliosa. Phytochem Lett. 2013;6:241–5.CrossRef
87.
Bringmann G, Mutanyatta-Comar J, Maksimenka K, Wanjohi JM, Heydenreich M, Brun R, et al. Joziknipholones A and B: the first dimeric phenylanthraquinones, from the roots of Bulbine frutescens. Chemistry. 2008;14:1420–9.PubMedCrossRef
88.
Abdissa D, Geleta G, Bacha K, Abdissa N. Phytochemical investigation of Aloe pulcherrima roots and evaluation for its antibacterial and antiplasmodial activities. PLoS ONE. 2017;12:e0173882.PubMedPubMedCentralCrossRef
89.
Feilcke R, Arnouk G, Raphane B, Richard K, Tietjen I, Andrae-Marobela K, et al. Biological activity and stability analyses of knipholone anthrone, a phenyl anthraquinone derivative isolated from Kniphofia foliosa Hochst. J Pharm Biomed Anal. 2019;174:277–85.PubMedCrossRef
90.
Lenta BN, Ngamgwe RF, Kamdem LM, Ngatchou J, Tantangmo F, Antheaume C, et al. Compounds from Diospyros canaliculata (Ebenaceae) and their antiparasitic activities. Int Res J Pure Appl Chem. 2015;6:56.CrossRef
91.
Geremedhin G, Bisrat D, Asres K. Isolation, characterization and in vivo antimalarial evaluation of anthrones from the leaf latex of Aloe percrassa Todaro. J Nat Remedies. 2014;14:1–7.
92.
Endale M, Ekberg A, Akala HM, Alao JP, Sunnerhagen P, Yenesew A, et al. Busseihydroquinones A-D from the roots of Pentas bussei. J Nat Prod. 2012;75:1299–304.PubMedCrossRef
93.
Namukobe J, Kiremire BT, Byamukama R, Kasenene JM, Akala HM, Kamau E, et al. Antiplasmodial compounds from the stem bark of Neoboutonia macrocalyx Pax. J Ethnopharmacol. 2015;162:317–22.PubMedCrossRef
94.
Douanla PD, Tabopda TK, Tchinda AT, Cieckiewicz E, Frédérich M, Boyom FF, et al. Antrocarines A-F, antiplasmodial ergostane steroids from the stem bark of Antrocaryon klaineanum. Phytochemistry. 2015;117:521–6.PubMedCrossRef
95.
Irungu BN, Adipo N, Orwa JA, Kimani F, Heydenreich M, Midiwo JO, et al. Antiplasmodial and cytotoxic activities of the constituents of Turraea robusta and Turraea nilotica. J Ethnopharmacol. 2015;174:419–25.PubMedPubMedCentralCrossRef
96.
Namukobe J, Kiremire BT, Byamukama R, Kasenene JM, Dumontet V, Guéritte F, et al. Cycloartane triterpenes from the leaves of Neoboutonia macrocalyx L. Phytochemistry. 2014;102:189–96.PubMedCrossRef
97.
Endale A, Bisrat D, Animut A, Bucar F, Asres K. In vivo antimalarial activity of a labdane diterpenoid from the leaves of Otostegia integrifolia Benth. Phytother Res. 2013;27:1805–9.PubMedCrossRef
98.
Nondo RS, Moshi MJ, Erasto P, Masimba PJ, Machumi F, Kidukuli AW, et al. Anti-plasmodial activity of Norcaesalpin D and extracts of four medicinal plants used traditionally for treatment of malaria. BMC Complement Altern Med. 2017;17:167.PubMedPubMedCentralCrossRef
99.
Mba’ning BM, Lenta BN, Noungoué DT, Antheaume C, Fongang YF, Ngouela SA, et al. Antiplasmodial sesquiterpenes from the seeds of Salacia longipes var. camerunensis. Phytochemistry. 2013;96:347–52.PubMedCrossRef
100.
Nyongbela KD, Makolo FL, Hoye TR, Efange SMN. Isolation and characterization of Sclerienone C from Scleria striatinux. Nat Prod Commun. 2016;11:5–6.PubMed
101.
Happi GM, Kouam SF, Talontsi FM, Lamshöft M, Zühlke S, Bauer JO, et al. Antiplasmodial and cytotoxic triterpenoids from the bark of the Cameroonian medicinal plant Entandrophragma congoënse. J Nat Prod. 2015;78:604–14.PubMedCrossRef
102.
Wahba AE, El-Sayed AKA, El-Falal AA, Soliman EM. New antimalarial lanostane triterpenes from a new isolate of Egyptian Ganoderma species. Med Chem Res. 2019;28:2246–51.CrossRef
103.
Bero J, Hérent MF, Schmeda-Hirschmann G, Frédérich M, Quetin-Leclercq J. In vivo antimalarial activity of Keetia leucantha twigs extracts and in vitro antiplasmodial effect of their constituents. J Ethnopharmacol. 2013;149:176–83.PubMedCrossRef
104.
Simelane MBC, Shonhai A, Shode FO, Smith P, Singh M, Opoku AR. Anti-plasmodial activity of some Zulu medicinal plants and of some triterpenes isolated from them. Molecules. 2013;18:12313–23.PubMedPubMedCentralCrossRef
105.
Happi GM, Kouam SF, Talontsi FM, Zühlke S, Lamshöft M, Spiteller M. Minor secondary metabolites from the bark of Entandrophragma congoense (Meliaceae). Fitoterapia. 2015;102:35–40.PubMedCrossRef
106.
Chukwujekwu JC, de Kock CA, Smith PJ, van Heerden FR, van Staden J. Antiplasmodial activity of compounds isolated from Erythrina caffra. S Afr J Bot. 2016;106:101–3.CrossRef
107.
Ledoux A, Maraetefau H, Jansen O, Etienne D, Quetin-Leclercq J, Clerc P, et al. Phytochemical profile and biological activity evaluation of Zanthoxylum heterophyllum leaves against malaria. Planta Med Lett. 2015;2:e10–1.CrossRef
108.
Fouokeng Y, Feusso HMF, Teinkela JEM, Noundou XS, Wintjens R, Isaacs M, et al. In vitro antimalarial, antitrypanosomal and HIV-1 integrase inhibitory activities of two Cameroonian medicinal plants: Antrocaryon klaineanum (Anacardiaceae) and Diospyros conocarpa (Ebenaceae). S Afr J Bot. 2019;122:510–7.CrossRef
109.
Bapela MJ. NMR-based metaboliomic study of medicinal plants used against malaria and the isolated bioactive alkaloids. Ph.D thesis, University of Pretoria, South Africa. 2016.
110.
Ludere MT, van Ree T, Vleggaar R. Isolation and relative stereochemistry of lippialactone, a new antimalarial compound from Lippia javanica. Fitoterapia. 2013;86:188–92.PubMedCrossRef
111.
Zofou D, Ntie-Kang F, Sippl W, Efange SMN. Bioactive natural products derived from the Central African flora against neglected tropical diseases and HIV. Nat Prod Rep. 2013;30:1098–200.PubMedCrossRef
112.
Ntie-Kang F, Lifongo LL, Mbaze LM, Ekwelle N, Owono LCO, Megnassan E, et al. Cameroonian medicinal plants: a bioactivity versus ethnobotanical survey and chemotaxonomic classification. BMC Complement Altern Med. 2013;13:147.PubMedPubMedCentralCrossRef
113.
Lifongo LL, Simoben CV, Ntie-Kang F, Babiaka SB, Judson PN. A bioactivity versus ethnobotanical survey of medicinal plants from Nigeria, West Africa. Nat Prod Bioprospect. 2014;4:1–19.PubMedPubMedCentralCrossRef
114.
Ntie-Kang F, Lifongo LL, Simoben CV, Babiaka SB, Sippl W, Mbaze LM. The uniqueness and therapeutic value of natural products from West African medicinal plants, part I: uniqueness and chemotaxonomy. RSC Adv. 2014;4:28728–55.CrossRef
115.
Titanji VPK, Zofou D, Ngemenya MN. The antimalarial potential of medicinal plants used for the treatment of malaria in Cameroonian folk medicine. Afr J Trad Cam. 2008;5:302–21.
116.
Metadata
Title
The potential of anti-malarial compounds derived from African medicinal plants: a review of pharmacological evaluations from 2013 to 2019
Authors
Boris D. Bekono
Fidele Ntie-Kang
Pascal Amoa Onguéné
Lydia L. Lifongo
Wolfgang Sippl
Karin Fester
Luc C. O. Owono
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2020
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-020-03231-7

Other articles of this Issue 1/2020

Malaria Journal 1/2020 Go to the issue

Research

Malaria outbreak investigation in a rural area south of Zimbabwe: a case–control study

Research

Combining next-generation indoor residual spraying and drug-based malaria control strategies: observational evidence of a combined effect in Mali

Research

Comparative analysis of asexual and sexual stage Plasmodium falciparum development in different red blood cell types

Research

IgG antibody response against Anopheles salivary gland proteins in asymptomatic Plasmodium infections in Narino, Colombia

Research

Rapid shifts in the age-specific burden of malaria following successful control interventions in four regions of Uganda

Research

Molecular characterization of Plasmodium falciparum DNA-3-methyladenine glycosylase

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits